This is the authors' abstract. We don't add key points for this paper.
In Brief Transplant recipients are at increased risk for tuberculosis (TB), which can adversely affect graft viability and patient survival. Scientific societies and official organizations have therefore issued guidelines and consensus statements for TB prevention and treatment. However, due to the poor supporting evidence, the current recommendations largely rely on expert opinion rather than on properly designed studies. In this overview, we aim to gather together the previous experience and compare and contrast the main current guidelines on the prevention and treatment of TB in solid organ transplantation and hematopoietic stem cell transplantation. This critical review of current guidelines on the prevention and treatment of tuberculosis underscores the current limitations of diagnostic tests and antituberculous treatments. Therefore, recommendations are still largely based on local epidemiology due to the paucity of robust evidence.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Muñoz et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: